Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer. | Int J Mol Sci | 2023 | 37298588 | PubTator, text mining | PubMed |
| Splicing Modulators Are Involved in Human Polyglutamine Diversification via Protein Complexes Shuttling between Nucleus and Cytoplasm. | Int J Mol Sci | 2023 | 37298574 | PubTator, text mining | PubMed |
| ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation. | Sci Adv | 2023 | 37267363 | PubTator, text mining | PubMed |
| Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasion. | Proc Natl Acad Sci U S A | 2023 | 37253006 | PubTator, text mining | PubMed |
| Expression and significant roles of the lncRNA NEAT1/miR-493-5p/Rab27A axis in ulcerative colitis. | Immun Inflamm Dis | 2023 | 37249278 | PubTator, text mining | PubMed |
| [The relationship between the expression of amplified in breast cancer 1、androgen receptor and tamoxifen resistance in breast cancer]. | Zhonghua Yi Xue Za Zhi | 2023 | 37246005 | PubTator, text mining | PubMed |
| Cellular myofibromas with SRF fusions: clinicopathological and molecular study of 3 cases of a rare entity and a potential mimic of sarcoma. | Hum Pathol | 2023 | 37245628 | PubTator, text mining | PubMed |
| Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer. | Pharmacol Res | 2023 | 37244387 | PubTator, text mining | PubMed |
| Machine Learning Generation of Dynamic Protein Conformational Ensembles. | Molecules | 2023 | 37241789 | PubTator, text mining | PubMed |
| An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management. | J Pers Med | 2023 | 37240924 | PubTator, text mining | PubMed |
| PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. | Antioxidants (Basel) | 2023 | 37237941 | PubTator, text mining | PubMed |
| The Action of Chemical Denaturants: From Globular to Intrinsically Disordered Proteins. | Biology (Basel) | 2023 | 37237566 | PubTator, text mining | PubMed |
| A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders. | Nat Commun | 2023 | 37231012 | PubTator, text mining | PubMed |
| PD-L1 expression, morphology, and molecular characteristic of a subset of aggressive uterine tumor resembling ovarian sex cord tumor and a literature review. | J Ovarian Res | 2023 | 37221583 | PubTator, text mining | PubMed |
| Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | 37220590 | PubTator, text mining | PubMed |
| Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines. | Noncoding RNA | 2023 | 37218992 | PubTator, text mining | PubMed |
| Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas. | Clin Epigenetics | 2023 | 37208732 | PubTator, text mining | PubMed |
| The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. | Biomedicines | 2023 | 37189677 | PubTator, text mining | PubMed |
| Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells. | Clin Transl Sci | 2023 | 37186419 | PubTator, text mining | PubMed |
| Hypoxia-inducible factor-1α regulates the interleukin-6 production by B cells in rheumatoid arthritis. | Clin Transl Immunology | 2023 | 37179532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=13